357 related articles for article (PubMed ID: 8889607)
1. The contribution of "cure by dapsone monotherapy' to the reduction of prevalence of leprosy in the State of Orissa, India, 1983-1993.
Patnaik PK; McDougall AC
Indian J Lepr; 1996; 68(3):223-6. PubMed ID: 8889607
[TBL] [Abstract][Full Text] [Related]
2. Implementation of tests for monitoring drug compliance of leprosy out-patients under multi-drug therapy.
Balakrishnan S; Kumar A; Rao BR; Patro TP
Indian J Lepr; 1986; 58(4):555-9. PubMed ID: 3572097
[TBL] [Abstract][Full Text] [Related]
3. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
Jing Z; Zhang R; Zhou D; Chen J
Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
[TBL] [Abstract][Full Text] [Related]
4. Multidrug therapy in leprosy can prevent relapse--a retrospective study.
Biswas S; Mondal KK
Indian J Lepr; 2002; 74(4):313-8. PubMed ID: 12624979
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological shift in leprosy in a rural district of central India following introduction of multi-drug therapy (April 1986 to March 1992 and April 1992 to March 2002).
Pandey A; Uddin MJ; Patel R
Lepr Rev; 2005 Jun; 76(2):112-8. PubMed ID: 16038244
[TBL] [Abstract][Full Text] [Related]
6. Trends in new case-detection leprosy in Bihar, India.
Vijayakumaran P; Prasad B; Krishnamurthy P
Indian J Lepr; 2006; 78(2):145-51. PubMed ID: 16927849
[TBL] [Abstract][Full Text] [Related]
7. [The frequency of the appearance of perforating foot ulcers in patients with Hansen's disease as a function of treatment with disulone alone or with polychemotherapy].
Mane I; Grauwin MY; Cartel JL
Acta Leprol; 1995; 9(3):127-31. PubMed ID: 7631583
[TBL] [Abstract][Full Text] [Related]
8. Trends in leprosy over fifty years in Gudiyatham Taluk, Vellore, Tamil Nadu.
Norman G; Raja Samuel Bhushanam JD; Samuel P
Indian J Lepr; 2006; 78(2):167-85. PubMed ID: 16927851
[TBL] [Abstract][Full Text] [Related]
9. The national leprosy eradication programme in India.
Mittal BN
World Health Stat Q; 1991; 44(1):23-9. PubMed ID: 2068822
[TBL] [Abstract][Full Text] [Related]
10. Selection of MDT strategies through epidemiometric modeling.
Lechat MF; Declercq EE; Misson CB; Vellut CM
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):296-301. PubMed ID: 2115904
[TBL] [Abstract][Full Text] [Related]
11. Integration of leprosy into GHS in India: a follow up study (2006-2007).
Pandey A; Rathod H
Lepr Rev; 2010 Dec; 81(4):306-17. PubMed ID: 21313976
[TBL] [Abstract][Full Text] [Related]
12. Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy.
Chen XS; Li WZ; Jiang C; Ye GY
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):371-8. PubMed ID: 10700910
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Sapkota BR; Shrestha K; Pandey B; Walker SL
Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
[TBL] [Abstract][Full Text] [Related]
14. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
[TBL] [Abstract][Full Text] [Related]
16. Relapse rates in patients treated with dapsone monotherapy and combinations of dapsone and thiambutosine, thiacetazone, isoniazid and streptomycin in the pre-MDT era.
Smith TC; Richardus JH
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):353-8. PubMed ID: 7525795
[TBL] [Abstract][Full Text] [Related]
17. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
[TBL] [Abstract][Full Text] [Related]
18. Global review of multidrug therapy (MDT) in leprosy.
Noordeen SK; Lopez Bravo L; Daumerie D
World Health Stat Q; 1991; 44(1):2-15. PubMed ID: 2068821
[TBL] [Abstract][Full Text] [Related]
19. Impact of multidrug therapy on leprosy in Baroda district (Gujarat).
Chopra NK; Agarwal JS; Pandya PG
Indian J Lepr; 1989 Apr; 61(2):179-89. PubMed ID: 2746026
[TBL] [Abstract][Full Text] [Related]
20. Fixed duration MDT in paucibacillary leprosy (classical and modified).
Nadkarni NJ; Grugni A; Kini MS
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):25-8. PubMed ID: 8326177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
